Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R B Mailman

Showing results (111-120 of 156) with videos related to

Pageof 16
Sort By:
Psychopharmacology|April 1, 1995
LSD and structural analogs: pharmacological evaluation at D1 dopamine receptorsV J Watts, C P Lawler, D R Fox, et al.
Alcoholism, Clinical and Experimental Research|January 1, 1981
Differential effects of TRH, amphetamine, naloxone, and fenmetozole on ethanol actions: attenuation of the effects of punishment and impairment of aerial righting reflexR A Vogel, G D Frye, K M Koepke, et al.
Psychopharmacology|January 1, 1981
Effect of 5,7-dihydroxytryptamine on serotonergic control of prolactin secretion and behavior in ratsC M Kuhn, R A Vogel, R B Mailman, et al.
Neuroscience|January 8, 2011
Differential involvement of striato- and cerebello-thalamo-cortical pathways in tremor- and akinetic/rigid-predominant Parkinson's diseaseM M Lewis, G Du, S Sen, et al.
Anxiety|January 1, 1994
Neuroendocrine responsivity to monoaminergic system probes in generalized social phobiaM E Tancer, R B Mailman, M B Stein, et al.
European Journal of Pharmacology|September 28, 1993
Dopamine D1 receptors: efficacy of full (dihydrexidine) vs. partial (SKF38393) agonists in primates vs. rodentsV J Watts, C P Lawler, J H Gilmore, et al.
Molecular Pharmacology|December 1, 1993
New sigma-like receptor recognized by novel phenylaminotetralins: ligand binding and functional studiesR G Booth, S D Wyrick, R J Baldessarini, et al.
Journal of Medicinal Chemistry|May 1, 1991
Synthesis and in vitro evaluation of 2,3-dimethoxy-5-(fluoroalkyl)-substituted benzamides: high-affinity ligands for CNS dopamine D2 receptorsJ E Bishop, C A Mathis, J M Gerdes, et al.
Brain Research|October 27, 1978
Behavioral and prolactin responses to 5-hydroxytryptophan in rats treated during development with 5,7-dihydroxytryptamineG R Breese, R A Vogel, C M Kuhn, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 13, 2001
Dinapsoline: characterization of a D1 dopamine receptor agonist in a rat model of Parkinson's diseaseA G Gulwadi, C D Korpinen, R B Mailman, et al.
Pageof 16

Showing results (111-120 of 156) with videos related to

Sort By:
Pageof 16
Psychopharmacology|April 1, 1995
LSD and structural analogs: pharmacological evaluation at D1 dopamine receptorsV J Watts, C P Lawler, D R Fox, et al.
Alcoholism, Clinical and Experimental Research|January 1, 1981
Differential effects of TRH, amphetamine, naloxone, and fenmetozole on ethanol actions: attenuation of the effects of punishment and impairment of aerial righting reflexR A Vogel, G D Frye, K M Koepke, et al.
Psychopharmacology|January 1, 1981
Effect of 5,7-dihydroxytryptamine on serotonergic control of prolactin secretion and behavior in ratsC M Kuhn, R A Vogel, R B Mailman, et al.
Neuroscience|January 8, 2011
Differential involvement of striato- and cerebello-thalamo-cortical pathways in tremor- and akinetic/rigid-predominant Parkinson's diseaseM M Lewis, G Du, S Sen, et al.
Anxiety|January 1, 1994
Neuroendocrine responsivity to monoaminergic system probes in generalized social phobiaM E Tancer, R B Mailman, M B Stein, et al.
European Journal of Pharmacology|September 28, 1993
Dopamine D1 receptors: efficacy of full (dihydrexidine) vs. partial (SKF38393) agonists in primates vs. rodentsV J Watts, C P Lawler, J H Gilmore, et al.
Molecular Pharmacology|December 1, 1993
New sigma-like receptor recognized by novel phenylaminotetralins: ligand binding and functional studiesR G Booth, S D Wyrick, R J Baldessarini, et al.
Journal of Medicinal Chemistry|May 1, 1991
Synthesis and in vitro evaluation of 2,3-dimethoxy-5-(fluoroalkyl)-substituted benzamides: high-affinity ligands for CNS dopamine D2 receptorsJ E Bishop, C A Mathis, J M Gerdes, et al.
Brain Research|October 27, 1978
Behavioral and prolactin responses to 5-hydroxytryptophan in rats treated during development with 5,7-dihydroxytryptamineG R Breese, R A Vogel, C M Kuhn, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 13, 2001
Dinapsoline: characterization of a D1 dopamine receptor agonist in a rat model of Parkinson's diseaseA G Gulwadi, C D Korpinen, R B Mailman, et al.
Pageof 16